The endocytosis of AMPA receptors (AMPARs) underlies several forms of synaptic plasticity, including NMDA receptor (NMDAR)-dependent long-term depression (LTD), but the molecular mechanisms responsible for this trafficking remain unknown. We found that PSD-95, a major postsynaptic density protein, is important for NMDAR-triggered endocytosis of synaptic AMPARs in rat neuron cultures because of its binding to A kinase-anchoring protein 150 (AKAP150), a scaffold for specific protein kinases and phosphatases. Knockdown of PSD-95 with shRNA blocked NMDAR-triggered, but not constitutive or mGluR-triggered, endocytosis of AMPARs. Deletion of PSD-95's Src homology 3 and guanylate kinase-like domains, as well as a point mutation (L460P), both of which inhibit binding of PSD-95 to AKAP150, also blocked NMDAR-triggered AMPAR endocytosis. Furthermore, expression of a mutant AKAP150 that does not bind calcineurin inhibited this NMDAR-triggered trafficking event. Our results suggest that PSD-95's interaction with AKAP150 is critical for NMDAR-triggered AMPAR endocytosis and LTD, possibly because these scaffolds position calcineurin in the appropriate subsynaptic domain.
Activity-dependent changes in the strength of excitatory synapses are believed to be important cellular mechanisms that contribute to the plasticity of neuronal networks underlying many forms of experiencedependent plasticity including learning and memory 1 . Long-term potentiation (LTP) and LTD triggered by the activation of NMDARs are extensively studied models for such synaptic modifications and compelling evidence suggests that they result, at least in part, from activity-dependent regulated trafficking of AMPARs to and away from synapses [1] [2] [3] [4] . The detailed molecular mechanisms underlying such AMPAR trafficking, however, are incompletely understood.
AMPARs are heteromeric complexes that are composed of combinations of four subunits termed GluR1-4 (also known as GluRA-D) 5, 6 . These complexes are thought to be clustered in the postsynaptic density (PSD) of synapses via the binding of closely associated accessory proteins known as TARPS (transmembrane AMPAR regulatory proteins) to members of the membrane-associated guanylate kinase (MAGUK) family of PDZ domain-containing scaffold proteins [2] [3] [4] 7, 8 . The most extensively studied MAGUK is PSD-95/SAP-90; changes in the levels of PSD-95 influence synaptic AMPAR content. Specifically, overexpression of PSD-95 in cultured hippocampal neurons enhances surface expression of AMPARs 9 and causes a large increase in AMPARmediated excitatory postsynaptic currents (EPSCs) in hippocampal slice cultures [10] [11] [12] [13] . Conversely, shRNA-mediated knockdown of PSD-95 decreases AMPAR EPSCs 11, [14] [15] [16] . This strong correlation between synaptic PSD-95 levels and synaptic strength suggests that changes in PSD-95 expression may be an important component of the mechanisms underlying NMDAR-dependent LTP and LTD. Consistent with this idea, overexpression of PSD-95 'occludes' LTP 10, 17 and enhances LTD 17 . Furthermore, biochemical modifications of PSD-95 leading to its loss from synapses, specifically ubiquitination 18 and depalmitoylation 19 , have been reported to be critically involved in the agonistinduced endocytosis of AMPARs in cultured neurons, an extensively studied model for synaptically induced LTD in slices [20] [21] [22] .
Recently, we examined the role of PSD-95 in LTD using the expression of different mutant forms of PSD-95 and shRNA-mediated knockdown of PSD-95, and we were able to molecularly dissociate the roles of PSD-95 in regulating basal synaptic strength and LTD 23 . Notably, the mutant constructs that were used to demonstrate a role for ubiquitination and depalmitoylation in the endocytosis of AMPARs were either not targeted to synapses or had no effect on LTD. Instead, evidence suggested that the C-terminal Src homology 3 (SH 3 ) and guanylate kinase-like (GK) domains of PSD-95 were required for LTD and, in particular, for their binding to AKAP79/150. AKAP79/150 is a protein that has been proposed to function as a scaffold for protein kinase A (PKA), protein kinase C and the Ca 2+ /calmodulin-dependent protein phosphatase calcineurin (also known as PP2B) in a range of cell types, positioning these enzymes adjacent to key protein substrates [24] [25] [26] . The notion that AKAP79/150 is important in LTD is particularly attractive, as PKA and calcineurin have been implicated in the regulation of AMPAR trafficking during this form of synaptic plasticity 1, 20, 27, 28 .
A limitation of our previous work 23 is that direct measurements of the effects of molecular manipulations of PSD-95 on NMDAR-triggered AMPAR endocytosis were not made because we used electrophysiological assays. This is particularly important because the effects of two of the PSD-95 mutant constructs on LTD were not consistent with their effects on agonist-induced endocytosis of AMPARs 18, 19 . Here we studied the role of PSD-95 and its interaction with AKAP150 in NMDAR-triggered AMPAR endocytosis using a molecular replacement strategy that allows simultaneous shRNA-mediated acute knockdown of endogenous PSD-95 and expression of mutant forms of recombinant PSD-95 in cultured hippocampal neurons. There are two important advantages to this approach. First, developmental compensatory adaptations that may occur during synaptogenesis and synapse maturation as a result of the loss of PSD-95 are minimized. Second, the function of heterologous constructs can be studied without the necessity of a dominant effect as required by a standard overexpression approach.
We found that acute knockdown of PSD-95 markedly reduced NMDAR-triggered endocytosis of synaptic AMPARs, but did not affect constitutive AMPAR endocytosis or the endocytosis of AMPARs triggered by metabotropic glutamate receptor (mGluR) activation. Disruption of the interaction between PSD-95 and AKAP150 strongly inhibited the NMDAR-dependent endocytosis of AMPARs, as did expression of an AKAP150 mutant lacking its calcineurin-binding domain. Furthermore, loss of PSD-95 from synapses was neither necessary nor sufficient for the endocytosis of synaptic AMPARs caused by NMDAR activation. These results are consistent with a model in which the binding of AKAP150 to PSD-95 is required to position calcineurin at the appropriate subsynaptic location so that it can be activated by Ca 2+ influx through NMDARs and contribute to the endocytosis of AMPARs that underlies one major form of LTD.
RESULTS

NMDAR activation triggers endocytosis of synaptic AMPARs
Rapid endocytosis of surface AMPARs can be triggered in cultured hippocampal neurons by application of glutamate receptor agonists, including glutamate itself, NMDA, AMPA and group I mGluR agonists [18] [19] [20] [21] [22] 29, 30 . However, the spatial pattern and intracellular trafficking of the endocytosed AMPARs may differ depending on the specific agonist used 20, 29, 31 . Because the goal of this study was to elucidate the role of PSD-95 and its interaction with AKAP79/150 in the NMDAR-triggered endocytosis of synaptic AMPARs, it was important to first establish that NMDAR activation did in fact lead to the loss of synaptic AMPARs under our experimental conditions. Consistent with previous results using a method that allows visualization of internalized AMPARs 20 , brief application of NMDA (100 mM for 3 min) in the presence of both AMPAR and mGluR antagonists (20 mM 6,7-dinitroquinoxaline-2,3-dione and 100 mM LY341495, respectively) caused substantial internalization of AMPARs throughout the cell (control: 1.0 ± 0.03, n ¼ 46; NMDA: 3.5 ± 0.25, n ¼ 25; internalized AMPAR immunoreactivity normalized to control condition; Fig. 1a,b) , including both distal and proximal portions of dendrites as well as in the soma. Treatment of cultures with AMPA (100 mM for 5 min) in the presence of the NMDAR antagonist D-(-)-2-amino-5-phosphonovaleric acid (D-APV; 50 mM) and the mGluR antagonist LY341495 (100 mM) also induced internalization of AMPARs (AMPA: 5.4 ± 0.24, n ¼ 33; Fig. 1a,b) . However, the spatial pattern of AMPAR endocytosis was markedly different than that induced by NMDA; internalized AMPARs were observed primarily in the soma and proximal dendrites, but not in distal dendrites. To quantify the differences in the localization of internalized AMPARs, we measured total AMPAR immunofluorescence in a 10-mm circumference around the soma (somatic endocytosis) and compared this with the total AMPAR immunofluorescence in the more distal dendrites (outside of this 10-mm circumference; dendritic endocytosis, see Methods). We observed that 67 ± 2% of the internalized AMPAR staining was dendritic 15 min after application of NMDA, whereas 80 ± 4% of the internalized AMPARs were somatic following application of AMPA (Fig. 1c,d) .
The majority of surface AMPAR puncta in the dendrites of cultured neurons are synaptic, as defined by colocalization with pre-or postsynaptic markers. It thus seemed likely that the internalized AMPARs in the dendrites were predominantly of synaptic origin. To test this prediction, we quantified the proportion of synapses containing detectable levels of surface AMPARs by staining for surface GluR1 clusters and counterstaining for Bassoon, a core component of the active zone that is commonly used to identify presynaptic terminals 32 . Application of NMDA substantially reduced the proportion of Bassoon puncta that colocalized with surface GluR1 puncta, whereas AMPA application had a modest effect on this measure (control: 75.2 ± 3.2%, n ¼ 20; NMDA: 21.8 ± 1.9%, n ¼ 17; AMPA: 59.5 ± 3.4%, n ¼ 21; number of puncta per condition ¼ 767-1,002; Fig. 1e,f) . These results confirm that brief application of NMDA caused the internalization of synaptic AMPARs and are consistent with previous work showing that NMDA application in this manner causes a decrease in miniature EPSCs 20 . Therefore, we used this manipulation to induce endocytosis of synaptic AMPARs in all of our experiments. 
PSD-95 knockdown inhibits endocytosis of synaptic AMPARs
To examine the role of PSD-95 in NMDAR-triggered endocytosis of synaptic AMPARs, we initially tested the consequences of acutely knocking down endogenous PSD-95 using a shRNA to PSD-95 (sh95) that was expressed in the cultured neurons via lentiviruses. This sh95 construct was highly effective, as evidenced by the almost complete absence of PSD-95 immunofluorescence measured 5-6 d after infection (control: 1.0 ± 0.04, n ¼ 35; sh95: 0.1 ± 0.02, n ¼ 29; Supplementary  Fig. 1 online) . Consistent with its effects on AMPAR EPSCs in slice cultures 11 , shRNA-mediated knockdown of PSD-95 reduced the surface expression of endogenous AMPARs by B40%, whereas simultaneously expressing both sh95 and green fluorescent protein (GFP)-tagged wildtype PSD-95 enhanced surface AMPAR expression to slightly above control levels (control: 1.0 ± 0.04, n ¼ 31; sh95: 0.6 ± 0.02, n ¼ 23; sh95:PSD-95: 1.2 ± 0.03, n ¼ 29; Fig. 2a,b) . These results confirm the efficacy of the sh95 construct and the molecular replacement strategy in cultured hippocampal neurons. However, because sh95 markedly reduced the surface expression of AMPARs, it was necessary to use an assay that permitted measurement of the proportion of surface AMPARs that were internalized following NMDA application to examine the specific role of PSD-95 in NMDAR-triggered AMPAR endocytosis. Using a procedure that allowed staining of both internalized and remaining surface AMPARs with different secondary antibodies 22 (see Methods and Supplementary Fig. 2 online), we found that knockdown of PSD-95 with sh95 caused an almost complete inhibition of NMDA-triggered internalization of AMPARs (control and NMDA: 2.3 ± 0.13, n ¼ 36; sh95 and NMDA: 1.3 ± 0.09, n ¼ 21; Fig. 2c,d ). This reduction in AMPAR endocytosis resulting from the knockdown of PSD-95 was rescued by expression of recombinant PSD-95 (sh95:PSD-95 and NMDA: 2.4 ± 0.16, n ¼ 23; Fig. 2c,d ), indicating that it was not a result of some nonspecific effects of the sh95. Notably, the knockdown of PSD-95 inhibited the NMDA-triggered endocytosis of AMPARs in the distal dendrites (10 mm away from the soma; control and NMDA, 2.8 ± 0.09; sh95 and NMDA, 1.2 ± 0.19; sh95:PSD-95 and NMDA, 3.0 ± 0.12; Fig. 2e ), but not in the soma (control and NMDA, 2.1 ± 0.11; sh95 and NMDA, 2.5 ± 0.17; sh95:PSD-95 and NMDA, 2.6 ± 0.22; Fig. 2f ). These results suggest that PSD-95 has a specific role in the NMDARtriggered endocytosis of synaptic AMPARs, but not somatic, presumably extrasynaptic, AMPARs. In this and all subsequent experiments, we compared the effects of sh95 and various PSD-95 and AKAP150 constructs on the surface expression and endocytosis of AMPARs with cells infected with lentivirus containing the control FUGW vector that expresses GFP (controls) to control for any possible consequences of lentivirus infections.
Several previous studies have reported that neither knockdown of PSD-95 with shRNA nor overexpression of PSD-95 affect the synaptic localization of NMDARs or NMDAR-mediated synaptic currents 9, 11, 12, 15, 23 . Nevertheless, to test whether knockdown of PSD-95 might have affected NMDAR synaptic localization and thereby influenced NMDA-triggered endocytosis of AMPARs in these experiments, we quantified the percentage of Bassoon puncta that colocalized with NMDAR puncta (identified using an antibody to the requisite NMDAR subunit NR1). Acute sh95-mediated knockdown of PSD-95 had no detectable effect on the synaptic localization of NMDARs (control: 74.5 ± 4.7%, n ¼ 15; sh95: 74 ± 1.2%, n ¼ 17; number of puncta per condition ¼ 476-622; Supplementary Fig. 3 online). This lack of effect of sh95 on NMDAR synaptic localization is consistent with previous studies and suggests a specific role for PSD-95 in AMPAR surface expression and trafficking.
AMPAR endocytosis occurs constitutively and is greatly enhanced not only by activation of NMDARs and AMPARs, but also by activation of group I mGluRs in a manner that presumably mimics mGluRtriggered LTD 30 . We therefore examined whether knockdown of PSD-95 influences these forms of AMPAR endocytosis (Fig. 3) . In contrast with its clear effects on NMDAR-triggered AMPAR endocytosis, neither expression of sh95 nor recombinant PSD-95 and sh95 had a detectable effect on constitutive endocytosis of AMPARs (sh95: 1.2 ± 0.09, n ¼ 28; sh95:PSD-95: 1.1 ± 0.11, n ¼ 21; Fig. 3a,c) . Similarly, sh95-mediated knockdown of PSD-95 had no effect on the increase in AMPAR endocytosis that was elicited by application of the group I mGluR agonist 3,5-dihydroxyphenylglycine (DHPG, 50 mM) (control and DHPG: 2.5 ± 0.15, n ¼ 33; sh95 and DHPG: 2.5 ± 0.08, n ¼ 28; Fig. 3b,d ). As with NMDA application, DHPG application caused endocytosis of AMPARs in both the soma and dendrites (15 min after DHPG application, 45.8 ± 3.1% of internalized AMPAR staining was dendritic; Fig. 3e ). Therefore, PSD-95 appears to be critical specifically for the endocytosis of synaptic AMPARs triggered by activation of NMDARs, but not for other forms of AMPAR endocytosis.
PSD-95 mutations affect NMDAR-triggered AMPAR endocytosis N-terminal domain modifications of PSD-95, specifically polyubiquitination and depalmitoylation, have been suggested to be important for agonist-induced endocytosis of AMPARs in dissociated cultured neurons and, by implication, LTD 18, 19 . These conclusions were supported by observations that expression of a mutant form of PSD-95 lacking its PEST motif, which prevented its polyubiquitination (PSD-95DPEST), strongly inhibited agonist-induced AMPAR endocytosis 18 , as did a form of PSD-95 that was prenylated and therefore resistant to the membrane dissociation caused by depalmitoylation 19 . In hippocampal slice cultures, however, these same mutant forms of PSD-95 were either not targeted to synapses (PSD-95DPEST) or did not inhibit LTD (PSD-95 prenyl) 23 . In an attempt to reconcile these discrepant results, we examined the effects of these PSD-95 constructs on NMDAR-triggered AMPAR endocytosis (Fig. 4) . Consistent with our observations in hippocampal slice cultures, PSD-95DPEST (fused to GFP) did not show the highly punctate dendritic expression that is typical of wild-type PSD-95 and did not affect the surface expression of AMPARs (PSD-95DPEST: 0.98 ± 0.03, n ¼ 43; Fig. 4a,b) . Furthermore, it had no detectable effect on NMDARtriggered endocytosis of AMPARs (control and NMDA: 2.2 ± 0.09, n ¼ 47; PSD-95DPEST and NMDA: 2.1 ± 0.10, n ¼ 35; Fig. 4e,f) . We next examined the effect of replacing endogenous PSD-95 with a form of PSD-95 containing a prenylation motif fused to GFP 19 . Once again, consistent with results from experiments using hippocampal slice culture 23 , this construct rescued the decrease in surface expression of AMPARs caused by the knockdown of PSD-95 (sh95: 0.5 ± 0.06, n ¼ 41; sh95:PSD-95pre: 1.2 ± 0.08, n ¼ 22; Fig. 4c,d) . However, it also rescued the NMDAR-triggered endocytosis of AMPARs (control and NMDA: 2.0 ± 0.16, n ¼ 18; sh95 and NMDA: 1.1 ± 0.09, n ¼ 22; sh95:PSD-95pre and NMDA: 1.8 ± 0.11, n ¼ 27; Fig. 4g,h ) suggesting that detachment of PSD-95 from the plasma membrane is not required for this form of AMPAR endocytosis.
Role of AKAP in NMDAR-triggered AMPAR endocytosis PSD-95 is a modular protein containing three consecutive PDZ domains, an SH 3 domain and an enzymatically inactive GK domain, each of which is thought to interact with specific subsets of cytoplasmic proteins 7 . One of these, AKAP79/150 binds to the SH 3 and/or GK domains and was of particular interest because it binds calcineurin, a protein phosphatase that is required for both NMDAR-dependent LTD and NMDARtriggered endocytosis of AMPARs 20, 27 . In addition, AKAP79/150 binds to PKA, an interaction that influences AMPAR trafficking 28, 33 . To examine whether binding of AKAP150 to PSD-95 is important specifically for NMDAR-triggered endocytosis of AMPARs, we first replaced endogenous PSD-95 with a form of PSD-95 lacking SH 3 and GK domains (PSD-95DSH 3 GK). Despite deletion of its SH 3 and GK domains, PSD-95DSH 3 GK still rescued the decrease in the surface expression of AMPARs caused by knockdown of endogenous PSD-95 (sh95: 0.5 ± 0.03, n ¼ 31; sh95:PSD-95DSH 3 GK: 1.1 ± 0.06, n ¼ 21; Fig. 5a,b) . However, unlike wildtype PSD-95, it did not rescue the decrease in NMDAR-triggered AMPAR endocytosis (control and NMDA: 2.3 ± 0.09, n ¼ 24; sh95 and NMDA: 1.4 ± 0.07, n ¼ 29; sh95:PSD-95DSH 3 GK and NMDA: 1.5 ± 0.04, n ¼ 20; Fig. 5c,d ).
The SH 3 and GK domains of PSD-95 interact with several proteins in addition to AKAP79/150 (ref. 7) . To test the effects of a form of PSD-95 that more specifically impaired its binding to AKAP79/150, we made a point mutation in the SH 3 domain (L460P), which has been reported to impair the binding of AKAP79/150 to the isolated SH 3 domain 33, 34 . When placed in full-length PSD-95, co-immunoprecipitation experiments in HEK293 cells using haemagglutinin-tagged mouse AKAP150 revealed that this point mutation (PSD-95L460P) greatly impaired the binding of PSD-95 to AKAP150 compared with wild-type PSD-95 (Fig. 6a) . When we replaced endogenous PSD-95 with PSD-95L460P, it rescued the decrease in surface expression of AMPARs that was caused by the acute knockdown of PSD-95 (sh95: 0.5 ± 0.03, n ¼ 19; sh95:PSD-95L460P: 1.2 ± 0.07, n ¼ 28; Fig. 6b,c) . However, PSD-95L460P did not rescue the reduction in NMDAR-triggered endocytosis of AMPARs caused by expression of sh95 (control and NMDA: 2.5 ± 0.05, n ¼ 24; sh95 and NMDA: 1.2 ± 0.09, n ¼ 22; sh95:PSD-95L460P and NMDA: 0.7 ± 0.03, n ¼ 28; Fig. 6d,e) .
PP2B binding to AKAP is required for AMPAR endocytosis
Thus far, our results suggested that AKAP150 interaction with PSD-95 is necessary for the endocytosis of AMPARs triggered by NMDAR activation. In addition to interacting with calcineurin (PP2B), AKAP150 binds to protein kinase C and PKA [24] [25] [26] , with the latter interaction being implicated in the delivery of AMPARs to synapses 28 .
To determine whether AKAP150 binding specifically to calcineurin is required for NMDAR-triggered AMPAR endocytosis, we examined the effects of expressing a form of mouse AKAP150 in which the sequence that has been reported to be essential for binding calcineurin (amino acids 613-655) is deleted 35, 36 . Before testing this AKAP150 deletion construct (AKAPDPP2B), we first overexpressed full-length, wild-type AKAP150 as a control (Fig. 7) . This modestly increased the surface expression of AMPARs (AKAP150: 1.4 ± 0.06, n ¼ 45; Fig. 7a,b) , but had no effect on NMDAR-triggered endocytosis of AMPARs (control and NMDA: 1.8 ± 0.11, n ¼ 36; AKAP150 and NMDA: 1.8 ± 0.06, n ¼ 33; Fig. 7c,d ). In contrast, although still increasing surface AMPAR expression as wild-type AKAP150 did (AKAPDPP2B: 1.4 ± 0.03, n ¼ 28; Fig. 7e,f) , expression of AKAPDPP2B almost completely blocked the AMPAR endocytosis triggered by NMDAR activation (control and NMDA: 2.1 ± 0.10, n ¼ 29; AKAPDPP2B and NMDA: 1.2 ± 0.06, n ¼ 21; Fig. 7g,h) .
Loss of synaptic PSD-95 and AKAP during NMDAR activation
Application of NMDA has been reported to cause trafficking of both PSD-95 and AKAP79/150 away from synapses 18, 37 . To determine whether the mutant forms of PSD-95 and AKAP150 that impaired NMDA-induced AMPAR endocytosis also impair the trafficking of these proteins away from synapses, we examined the synaptic localization of these constructs following NMDA application by counterstaining with an antibody to the presynaptic marker protein Bassoon. Application of NMDA caused a moderate decrease in the proportion of synapses that contain detectable levels of endogenous PSD-95, as well as a similar decrease in the synaptic localization of full-length recombinant PSD-95 when expressed with sh95 (endogenous PSD-95: control, 71.3 ± 2.4%, n ¼ 18; NMDA, 54.8 ± 2.3%, n ¼ 21; sh95:PSD-95: control, 81.6 ± 2.1%, n ¼ 23; NMDA, 59.3 ± 2.5%, n ¼ 21; Fig. 8a,b) . Similar to the behavior of wild-type PSD-95, NMDA application caused a loss of PSD-95 from synapses expressing sh95:PSD-95DSH 3 GK and synapses expressing sh95:PSD-95L460P, the PSD-95 constructs that impaired or blocked NMDAR-triggered endocytosis of AMPARs (sh95:PSD-95DSH 3 GK: control, 75.1 ± 3.4%, n ¼ 19; NMDA, 33 ± 3.9%, n ¼ 14;
sh95:PSD-95L460P: control, 75.6 ± 1.8%, n ¼ 20; NMDA, 58 ± 4.2%, n ¼ 16; Fig. 8a,b) . In marked contrast, the synaptic localization of the prenylated PSD-95 (sh95 and PSD-95pre) was unaffected by NMDA application (Sh95:PSD-95pre: control, 75.4 ± 3%, n ¼ 22; NMDA, 75.7 ± 2.6%, n ¼ 21; Fig. 8a,b) . Together, these results demonstrate that the loss of PSD-95 from synapses caused by NMDAR activation can be completely dissociated from the NMDAR-triggered endocytosis of synaptic AMPARs. The behavior of PSD-95DSH 3 GK and PSD-95L460P demonstrate that the NMDA-induced loss of PSD-95 from synapses is not sufficient for NMDAR-triggered AMPAR endocytosis, whereas the behavior of PSD-95pre demonstrates that PSD-95 movement away from synapses is not necessary for synaptic AMPAR endocytosis.
The behavior of AKAP150 was similar to PSD-95 in that NMDA application lead to a loss of both endogenous and full-length AKAP150 from synapses (endogenous AKAP150: control, 61.5 ± 3%, n ¼ 17; NMDA, 38.3 ± 3.6%, n ¼ 18; AKAP150: control, 69.4 ± 4.1%, n ¼ 18; NMDA, 46.1 ± 2.8%, n ¼ 16; Fig. 8c,d) . However, the AKAP mutant that greatly impaired NMDAR-triggered AMPAR endocytosis (AKAPDPP2B) behaved the same as wild-type AKAP150 did, indicating that, as with PSD-95, movement of AKAP150 away from synapses is not sufficient to elicit endocytosis of synaptic AMPARs (AKAPDPP2B: control, 66.4 ± 2.5%, n ¼ 19; NMDA, 33.9 ± 3.7%, n ¼ 23; Fig. 8c,d ).
DISCUSSION
The detailed molecular mechanisms underlying the trafficking of AMPARs into and out of synapses are of great interest because of their importance in prominent forms of synaptic and experience-dependent plasticity 1-4 . One important molecular component is PSD-95, a member of the MAGUK family of synaptic scaffolding proteins 2-4,7,8 . Molecular manipulations have demonstrated that changes in the levels of PSD-95 correlate with synaptic AMPAR content [9] [10] [11] [12] [13] [14] [15] [16] [17] and it has been suggested that biochemical modifications of PSD-95 leading to its loss from synapses contributes to agonist-induced endocytosis in cultured neurons 18, 19 . However, using electrophysiological assays in hippocampal slice cultures, we found that the mutant forms of PSD-95 that were reported to block AMPAR endocytosis did not influence synaptic strength and LTD in the expected manner. Instead, on the basis of the effects of a series of mutant PSD-95 constructs, we proposed that PSD-95 is as a scaffold for one or more of the signaling proteins that are required for the triggering of NMDAR-dependent LTD 23 .
To address whether this hypothesis applies to the endocytosis of AMPARs that is thought to mediate LTD 1-4 , we found it was necessary to directly measure the effects of mutant forms of PSD-95 on agonist-induced endocytosis of endogenous AMPARs, a process that is routinely assayed in cultured neurons. Primarily using a strategy in which mutant forms of PSD-95 replace endogenous PSD-95 that has been knocked down by shRNA, we found that PSD-95 is important for the NMDAR-triggered endocytosis of synaptic AMPARs, at least in part because of its binding to AKAP150. This is an attractive hypothesis because AKAP79/150 binds to calcineurin [24] [25] [26] , a phosphatase that is required for both NMDAR-dependent LTD and NMDAR-triggered AMPAR endocytosis 20, 27 . We propose that the binding of AKAP150 to PSD-95 positions calcineurin at the mouth of the NMDAR channel so that it can be readily activated by the modest rises in Ca 2+ that is thought to be responsible for triggering NMDAR-dependent LTD 38 .
The NMDAR-triggered AMPAR endocytosis was not affected by expression of two mutant forms of PSD-95, PSD-95DPEST and PSD95pre, which have previously been reported to inhibit agonist-induced AMPAR endocytosis 18, 19 . One explanation for this discrepancy is that the treatment protocols that were used in the previous experiments primarily caused endocytosis of extrasynaptic AMPARs, whereas the protocol that we used elicits the loss of synaptic AMPARs in the plasma membrane. It is also possible that the expression levels of the constructs or culture conditions account for the differences. Confidence in our results is greatly increased by the fact that our observations of the effects of these two constructs in dissociated hippocampal neuron cultures are exactly what would be predicted from results obtained in hippocampal slice cultures 23 . There is one discrepancy with our previous results, however, in that PSD-95DSH 3 GK caused a clear rescue of the surface expression of AMPARs caused by the PSD-95 knockdown in the dissociated cultures, whereas PSD-95DSH 3 GK did not rescue basal AMPAR-mediated synaptic transmission in the hippocampal slice cultures 23 . This discrepancy may be the result of differences in the trafficking of AMPARs to the surface in the two preparations or because of differences in the levels of expression of other MAGUKs, such as the developmentally regulated SAP-102 (ref. 15) , which may have helped target PSD-95 to the plasma membrane in cultured neurons, but not in slices.
We have presented several lines of evidence that specifically implicate the interaction of PSD-95 with AKAP150 as being critical for NMDARtriggered endocytosis of synaptic AMPARs. Wild-type PSD-95 completely reversed the consequences of knocking down endogenous PSD-95 on both surface expression of AMPARs and NMDAR-triggered AMPAR endocytosis. In contrast, both PSD-95DSH 3 GK and PSD-95L460P rescued AMPAR surface expression, while having no effect on the impairment of AMPAR endocytosis induced by sh95 expression. Although the deletion of the SH 3 and GK domains would be expected to impair PSD-95's interactions with proteins other than AKAP150, such as GKAP/SAPAP and SPAR, the L460P mutation is thought to be highly specific 33, 34 , and we demonstrated that it strongly impaired PSD-95's ability to interact with AKAP150 when placed in full-length PSD-95. Furthermore, expression of a mutant form of AKAP150 lacking its calcineurin binding site 35, 36 almost completely blocked NMDAR-triggered AMPAR endocytosis. The scaffolding of calcineurin by AKAP79/150 also appears to regulate L-type Ca 2+ channel activity in hippocampal neurons as a result of the direct binding of AKAP79/150 to Ca v 1.2 (ref. 39 ). This AKAP-dependent coupling of calcium entry via L-type Ca 2+ channels to calcineurin is consistent with previous observations that activation of these channels can induce a form of LTD, which occludes NMDAR-dependent LTD 38 , and that the endocytosis of AMPARs triggered by Ca 2+ channel activation is blocked by calcineurin inhibitors 20 . It will be important to investigate whether these findings from dissociated hippocampal cultures hold true when LTD is studied in more intact preparations such as hippocampal slices.
The simplest model to explain our results is that the interaction between PSD-95 and AKAP150 is important for NMDAR-triggered AMPAR endoctyosis and LTD because it statically positions calcineurin in the appropriate subsynaptic domain. Several observations, however, suggest that these protein interactions may be much more dynamic and regulated by activity. Calcineurin activity is reduced when it is bound to AKAP79/150 (refs. 40, 41) and PSD-95 and calcineurin may compete for binding to AKAP79/150 (ref. 33) . Furthermore, the synaptic localization of AKAP79/150 is influenced by NMDARdependent activity in a calcineurin-dependent manner 25, 37, 42 . Thus, it is possible that in the basal state AKAP79/150 is bound to calcineurin, which is largely inactive. On appropriate NMDAR activation, AKAP79/ 150 binds to PSD-95, causing the release of calcineurin, which is activated and can then function in AMPAR endocytosis. Subsequently, AKAP79/150 may leave the spine, a step that could contribute to LTD by removing a pool of PKA required for the maintenance of synaptic AMPARs 25, 28, 43 .
AMPARs also interact with stargazin and related TARPs, which are important in the synaptic clustering of AMPARs via their interactions with MAGUKs such as PSD-95 (ref. 8) . Furthermore, phosphorylation of stargazin can be dynamically regulated by NMDAR activity in a manner that influences LTP and LTD 44 and AMPARs can dissociate from TARPS on binding glutamate 45 . Thus, the interactions between PSD-95 and AMPARs via TARPS may be another important site of modulation for regulating AMPAR surface expression and NMDARtriggered endocytosis of AMPARs.
Because loss of PSD-95 and AKAP79/150 from synapses has been suggested to be important for endocytosis of synaptic AMPARs, we examined whether such trafficking was directly correlated with NMDAR-triggered AMPAR endocytosis. Mutant constructs of PSD-95 and AKAP150 that clearly impaired the endocytosis of synaptic AMPARs were lost from synapses on NMDA application to the same degree as wild-type PSD-95 and AKAP150, indicating that such movements of PSD-95 and AKAP150 are not sufficient to elicit endocytosis of synaptic AMPARs. Conversely, the synaptic localization of the prenylated form of PSD-95, which permitted normal endocytosis of AMPARs on NMDAR activation, was not affected by NMDA application. This indicates that the loss of PSD-95 from synapses is not necessary for NMDAR-triggered endocytosis of synaptic AMPARs and provides further evidence that PSD-95 and AKAP150 function as scaffolds for signaling proteins.
Our results also suggest that the role of PSD-95 in endocytosis of synaptic AMPARs is highly specific. Knockdown of PSD-95 markedly reduced NMDAR-triggered AMPAR endocytosis in dendrites independent of its effects on surface expression but did not influence constitutive AMPAR endocytosis, NMDAR-triggered AMPAR endocytosis in the soma or mGluR-triggered AMPAR endocytosis. That PSD-95 is specifically important in NMDAR-dependent processes at synapses is further supported by the observations that mGluR-triggered LTD and AMPAR endocytosis involve signaling cascades that are distinct from those underlying NMDAR-triggered LTD 30, [46] [47] [48] in a manner that does not require PSD-95, but instead requires different scaffolding proteins such as Homer 49 . 
METHODS
Hippocampal cultures and lentivirus infection. Primary hippocampal neuron cultures were prepared from P0 Sprague-Dawley rat pups as described previously with minor changes 20 . Briefly, hippocampi were obtained from P0 rat pups and the dentate gyri were removed. Tissue was dissociated by papain treatment and cells were plated on poly-D-lysine-coated cover slips at a density of approximately 75,000 cells per 12-mm well. Cultures were maintained in minimum essential media (Invitrogen) with 0.5 mM glutamine and N2 supplement. Glial growth was inhibited by adding FUDR (floxuridine) after 1 week in culture. Neurons were infected with lentiviruses after 9-10 d in vitro and used in experiments after 15-17 d in vitro. An shRNA to PSD-95 was packaged into lentiviruses, which were produced as previously described 11 . For molecular replacement studies, the enhanced GFP (eGFP) in the lentiviral vector containing the shRNA was replaced by the C-terminal eGFP-tagged protein of interest (that is, PSD-95, PSD-95pre, PSD-95DSH 3 GK and PSD-95L460P). The overexpression constructs were cloned into the FUGW vector and tagged at the C terminus with eGFP. Detailed strategies for producing these constructs have been described previously 23 . Mouse AKAP150 cDNA was cloned from total hippocampal RNA (see Supplementary Methods online for further details on these procedures).
Immunocytochemistry and image analysis. Details of the procedures used to assay surface expression and endocytosis of AMPARs can be found in the Supplementary Methods. In all experiments, we labeled surface AMPARs in live neurons by incubation with a rabbit polycloncal antibody (Calbiochem) directed to the N terminus of the GluR1 subunit and then induced endocytosis with various pharmacological manipulations. Synaptic localization of AMPAR, NMDAR, PSD-95 and AKAP150 puncta were quantified by their colocalization with presynaptic Bassoon puncta (see Supplementary Methods for further details). For image acquisition, coverslips were mounted in Fluormount (Electron Microscopy Sciences) and cells were imaged with a 63Â oil-immersion objective mounted on a Zeiss LSM 510 laser-scanning confocal microscope. Images for all conditions in a particular experiment were obtained using identical acquisition parameters and were analyzed with Metamorph software using identical parameters (Meta imaging series 5.0 and 6.1, Universal Imaging). All analyses were done blind, without knowledge of the experimental manipulation that had been performed using raw images. Untreated and treated cells from the same culture preparation were always compared with one another for each experimental manipulation (see Supplementary Methods for further details). Synaptic GluR1, NR1, endogenous PSD-95, endogenous AKAP150, recombinant PSD-95 and recombinant AKAP150 puncta were defined by visual colocalization with presynaptic Bassoon puncta along 50-mm portions of dendrite (see Supplementary Methods for further details).
Statistical analysis. The n value given for each experiment refers to the number of cells analyzed. Data are presented as mean ± s.e.m. Group results were compared by using Student's t test. P 4 0.05 was considered not significant.
Immunoprecipitation and immunoblotting. HEK293 cells were transfected at 70-80% confluency with expression constructs. Cells were harvested and lysed 24 h after transfection in RIPA buffer (1% Triton X-100, 0.1% SDS, 0.5% deoxycholic acid, 50 mM NaPO 4 , 150 mM NaCl and protease inhibitor cocktail (Roche), pH 7.4) for 1 h at 4 1C. Immunoprecipitation was done by overnight incubation of the lysates with antibody to GFP at 4 1C (Molecular probes, Invitrogen) and subsequent additional incubation for 1 h at (21-23 1C) with protein A agarose beads (Roche). The immunoprecipitates were washed and solubilized in SDS-PAGE sample buffer. Samples were separated on 4-12% gradient Bis-Tris gels (Invitrogen) and transferred onto nitrocellulose. Immunoblotting was performed using horseradish peroxidase-conjugated secondary antibodies and the ECL western blotting detection system (Amersham Biosciences). For immunoblotting, antibodies to GFP (Chemicon) and haemagglutinin (Roche) were used.
Note: Supplementary information is available on the Nature Neuroscience website. 
